US 12409167
Pharmaceutical combination comprising a selective S1P1 receptor agonist
granted A61KA61K31/22A61K31/225
Quick answer
US patent 12409167 (Pharmaceutical combination comprising a selective S1P1 receptor agonist) held by VANDA PHARMACEUTICALS INC. expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VANDA PHARMACEUTICALS INC.
- Grant date
- Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/22, A61K31/225, A61K31/27, A61K31/4015